Latest News » Curcumin extract used in early Alzheimer’s detection trials

A new type of eye exam could one day lead to early Alzheimer's disease detection.

The role of curcumin, the active ingredient of the spice turmeric, has long been established in degenerative brain medicine. A new utilization of this nutrient suggests that some folks might be able to catch the development of Alzheimer's disease years before this life-threatening condition becomes symptomatic.

According to Primary Care Optometry News (PCON), an industry media source, Alzheimer's disease manifests itself through memory loss, deterioration in motor function and general life impairment. Yet by the time that doctors are able to identify the disorder, it's generally too late to do more than treat the symptoms. A new theory posits that amyloid beta protein deposits, which form throughout the body as we age and are considered to be potential biomarkers for Alzheimer's, could be seen in the eyes years before the more debilitating effects of the disease start to show. 

Early testing has been promising, PCON reported. In an interview, Dr. Kevin Black of the Cedars-Sinai Medical Center in Los Angeles, California, suggested that a curcumin compound combined with a retinal scanner could yield a more definitive diagnosis in those potentially suffering from Alzheimer's. 

"An increase in fluorescence that we can detect with the retinal imager is directly proportional to the amount of amyloid protein in the back of the eye, which correlates with the amount of amyloid protein in the brain," Black told the source.

This new research highlights the continued importance of curcumin in maintaining a well-ness-oriented lifestyle. Want to learn more about products that you can buy which incorporate the benefits of curcumin? If so, click here to learn more about Nutrivene Longvida Curcumin.